FGFR2 and cholangiocarcinoma: The absence of SHTN1 expression in healthy cholangiocytes, in contrast to the physiological presence of FGFR2, underscores how this fusion creates an entirely novel chimeric protein with aberrant signaling potential in the cells critical for CCA initiation and progression.